Showing results (1301-1310 of 19,270) with videos related to
Sort By:
Pageof 1,927
Transplantation|February 27, 1995
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantationK L Cox, L S Lawrence-Miyasaki, R Garcia-Kennedy, et al.Transplantation|February 27, 1995
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter TrialS V McDiarmid, R W Busuttil, N L Ascher, et al.Transplantation|March 15, 1995
Optimization of the magnetic field used for immunomagnetic islet purificationJ E Davies, R F James, N J London, et al.Transplantation|April 15, 1995
Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant centerA M Goetz, O K Ndimbie, M M Wagener, et al.Transplantation|April 27, 1995
Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusionK R McCurry, D L Kooyman, L E Diamond, et al.Transplantation|April 27, 1995
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibitionH Miyazawa, N Murase, A J Demetris, et al.Transplantation|May 27, 1995
In vivo studies of the maintenance of peripheral transplant tolerance after cyclosporine. Radiosensitive antigen-specific suppressor cells mediate lasting graft protection against primed effector cellsS J Nisco, R J Hissink, P W Vriens, et al.Transplantation|May 27, 1995
Association of down-regulation of cytokine activity with rat hind limb allograft survivalM J Fealy, D Most, P Huie, et al.Transplantation|November 1, 1993
The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allograftsP K KoskinenTransplantation|November 1, 1993
The effect of FK506 on canine bile flowJ C Reese, R B Fairchild, H Solomon, et al.Pageof 1,927